We are live on
!
Find out more
LGM
Logos Global Management Portfolio holdings
AUM
$1.94B
1-Year Est. Return
444.09%
This Fund
S&P 500
This Quarter
Est. Return
+47.39%
1 Year Est. Return
+444.09%
3 Year Est. Return
+1,593.63%
5 Year Est. Return
+2,146.66%
10 Year Est. Return
–
AUM
$1.94B
AUM Growth
+$441M
(+29%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
8.14%
Top 10 Holdings %
Top 10 Hldgs %
50.91%
Holding
78
New
12
Increased
23
Reduced
21
Closed
13
Top Buys
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$49.2M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$40.6M |
| 3 |
United Therapeutics
UTHR
|
+$39.8M |
| 4 |
Cytokinetics
CYTK
|
+$36.5M |
| 5 |
ABVX
Abivax
ABVX
|
+$32.5M |
Top Sells
| 1 |
CDTX
Cidara Therapeutics
CDTX
|
+$68.5M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$36.1M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$34M |
| 4 |
Praxis Precision Medicines
PRAX
|
+$27.8M |
| 5 |
Erasca
ERAS
|
+$21.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
MeiraGTx Holdings
MGTX
$1.16B
| $6.06M | 0.31% |
+700,000
| New | +$5.32M |
|
|
JBIO
52
Jade Biosciences
JBIO
$1.33B
| $5.62M | 0.29% |
400,000
+5,000
| +1% | +$72.4K |
|
53
Verastem
VSTM
$504M
| $5.3M | 0.27% |
1,000,000
-700,000
| -41% | -$4.32M |
|
54
Avalo Therapeutics
AVTX
$975M
| $4.48M | 0.23% |
+300,000
| New | +$4.69M |
|
55
Unicycive Therapeutics
UNCY
$138M
| $3.12M | 0.16% |
473,563
| – | – |
|
56
iBio
IBIO
$71M
| $2.47M | 0.13% |
1,300,000
-700,000
| -35% | -$1.62M |
|
|
PTN
57
Palatin Technologies
PTN
$15.8M
| $2.44M | 0.13% |
140,000
| – | – |
|
58
Aclaris Therapeutics
ACRS
$782M
| $1.88M | 0.1% |
500,000
-100,000
| -17% | -$337K |
|
59
Pharvaris
PHVS
$2.46B
| $1.84M | 0.09% |
65,000
-35,000
| -35% | -$935K |
|
|
MANE
60
Veradermics Inc
MANE
$5.17B
| $1.58M | 0.08% |
+25,000
| New | +$1.26M |
|
|
FTH
61
Faeth Therapeutics
FTH
$811M
| $946K | 0.05% |
+30,000
| New | +$599K |
|
|
SEPN
62
Septerna Inc
SEPN
$1.54B
| $566K | 0.03% |
23,548
| – | – |
|
63
Fractyl Health
GUTS
$144M
| $458K | 0.02% |
1,000,000
-100,000
| -9% | -$92.2K |
|
|
ACLX
64
DELISTED
Arcellx
ACLX
| – | – |
-115,000
| Closed | -$7.5M |
|
|
APLS
65
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
0
| – | – |
|
|
CDTX
66
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-310,000
| Closed | -$68.5M |
|
|
DAWN
67
DELISTED
Day One Biopharmaceuticals
DAWN
| – | – |
-300,000
| Closed | -$2.8M |
|
|
DBVT
68
DBV Technologies
DBVT
$930M
| – | – |
-25,000
| Closed | -$479K |
|
69
Immatics
IMTX
$1.29B
| – | – |
0
| – | – |
|
|
70
Jazz Pharmaceuticals
JAZZ
$15B
| – | – |
-200,000
| Closed | -$34M |
|
71
Kiniksa Pharmaceuticals
KNSA
$4.75B
| – | – |
-350,000
| Closed | -$14.4M |
|
72
Kymera Therapeutics
KYMR
$9.39B
| – | – |
-130,000
| Closed | -$10.1M |
|
|
MREO
73
Mereo BioPharma
MREO
$52.3M
| – | – |
-1,850,000
| Closed | -$771K |
|
74
Neurogene
NGNE
$787M
| – | – |
-195,000
| Closed | -$4.02M |
|
75
Nurix Therapeutics
NRIX
$2.48B
| – | – |
-500,000
| Closed | -$9.48M |
|
Similar funds
NFG
FFH
BC
MWA
WPC
OCM
1SB
FM